Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.

The oral route administration of protein and peptide drug has been limited by low bioavailability due to extensive hydrolysis and proteolytic enzymes activity in the gastrointestinal (GI) tract. Hence, chitosan-κ-carrageenan polyelectrolyte complex matrix that exhibit pH-dependent swelling character...

Full description

Saved in:
Bibliographic Details
Main Author: Chow, Sharan Mei Wei.
Other Authors: Wang Kean
Format: Final Year Project
Language:English
Published: 2009
Subjects:
Online Access:http://hdl.handle.net/10356/16638
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-16638
record_format dspace
spelling sg-ntu-dr.10356-166382023-03-03T15:36:17Z Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier. Chow, Sharan Mei Wei. Wang Kean School of Chemical and Biomedical Engineering DRNTU::Engineering::Chemical engineering::Biotechnology The oral route administration of protein and peptide drug has been limited by low bioavailability due to extensive hydrolysis and proteolytic enzymes activity in the gastrointestinal (GI) tract. Hence, chitosan-κ-carrageenan polyelectrolyte complex matrix that exhibit pH-dependent swelling characteristic is introduced as a biodegradable vesicle for oral administration. The chitosan-carrageenan particles was synthesized using chitosan and κ-carrageenan solutions at 500rpm. A model protein, bovine serum albumin (BSA), was loaded into the particles synthesized by incubating the particles in protein solution at pH4.5. The release of protein from the freeze-dried polyplex particles were tested in simulated gastric fluid (SGF pH1.2) and simulated intestinal fluid (SIF pH7.5) at different time intervals. Within 4 hours incubation, the particles released only 7% of loaded protein in SGF but higher amount of loaded protein (25%) in SIF, which shows higher stability of the polyplex particles in gastric environment. To mimic the physiological GI conditions, the particles were first incubated in SGF for 4 hours and were transferred to SIF for additional release study. 2% of BSA release was detected after 4 hour incubation in SGF and 12% of total release was attained after another 4 hour incubation in SIF. In addition, another batch of BSA encapsulated particles was prepared via incorporation method and tested for the protein release profiles in identical procedures. The results suggest that a better protein loading efficiency is attained. The findings from this project is encouraging and offer good potential for the further investigation of chitosan-carrageenan polyplex particles as new protein drug carrier. Bachelor of Engineering (Chemical and Biomolecular Engineering) 2009-05-27T08:12:13Z 2009-05-27T08:12:13Z 2009 2009 Final Year Project (FYP) http://hdl.handle.net/10356/16638 en Nanyang Technological University 97 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Engineering::Chemical engineering::Biotechnology
spellingShingle DRNTU::Engineering::Chemical engineering::Biotechnology
Chow, Sharan Mei Wei.
Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
description The oral route administration of protein and peptide drug has been limited by low bioavailability due to extensive hydrolysis and proteolytic enzymes activity in the gastrointestinal (GI) tract. Hence, chitosan-κ-carrageenan polyelectrolyte complex matrix that exhibit pH-dependent swelling characteristic is introduced as a biodegradable vesicle for oral administration. The chitosan-carrageenan particles was synthesized using chitosan and κ-carrageenan solutions at 500rpm. A model protein, bovine serum albumin (BSA), was loaded into the particles synthesized by incubating the particles in protein solution at pH4.5. The release of protein from the freeze-dried polyplex particles were tested in simulated gastric fluid (SGF pH1.2) and simulated intestinal fluid (SIF pH7.5) at different time intervals. Within 4 hours incubation, the particles released only 7% of loaded protein in SGF but higher amount of loaded protein (25%) in SIF, which shows higher stability of the polyplex particles in gastric environment. To mimic the physiological GI conditions, the particles were first incubated in SGF for 4 hours and were transferred to SIF for additional release study. 2% of BSA release was detected after 4 hour incubation in SGF and 12% of total release was attained after another 4 hour incubation in SIF. In addition, another batch of BSA encapsulated particles was prepared via incorporation method and tested for the protein release profiles in identical procedures. The results suggest that a better protein loading efficiency is attained. The findings from this project is encouraging and offer good potential for the further investigation of chitosan-carrageenan polyplex particles as new protein drug carrier.
author2 Wang Kean
author_facet Wang Kean
Chow, Sharan Mei Wei.
format Final Year Project
author Chow, Sharan Mei Wei.
author_sort Chow, Sharan Mei Wei.
title Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
title_short Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
title_full Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
title_fullStr Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
title_full_unstemmed Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
title_sort chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
publishDate 2009
url http://hdl.handle.net/10356/16638
_version_ 1759855574983376896